Blood Cancer
Showing 1 - 25 of 26
Immune Profiling for Cancer Immunotherapy Response
Recruiting
- Cancer
- +3 more
- Methylation Cytometry
-
Lebanon, New HampshireDartmouth-Hitchcock Medical Center
Nov 6, 2023
Blood Cancer, Refractory Immune Cytopenias Trial in United States (Isatuximab)
Not yet recruiting
- Blood Cancer
- Refractory Immune Cytopenias
- Isatuximab
-
Basking Ridge, New Jersey
- +6 more
May 15, 2023
Among Pediatric Brain Tumor and Blood Cancer Patients
Recruiting
- Brain Tumor, Pediatric
- Blood Cancer
- Neurocognitive tools
-
Karachi, Sindh, PakistanNida Zahid
Jan 30, 2023
Hematologic Malignancy, Blood Cancer, Lymphoma Trial in Boston (Palliative Care, Usual Care)
Recruiting
- Hematologic Malignancy
- +4 more
- Palliative Care
- Usual Care
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Jan 24, 2023
Chronic Graft-versus-Host-Disease, Allogeneic Hematopoietic Stem Cell Transplantation, Leukemia Trial
Not yet recruiting
- Chronic Graft-versus-Host-Disease
- +4 more
- (no location specified)
Jan 11, 2023
Hematologic Malignancy, Hematopoietic/Lymphoid Cancer, Blood Cancer Trial in Boston (Positive Psychology Intervention)
Completed
- Hematologic Malignancy
- +2 more
- Positive Psychology Intervention
-
Boston, MassachusettsDana Farber Cancer Institute
Nov 14, 2022
Non-Hodgkin's B-cell Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Leukemia Trial in Worldwide (MT-3724
Terminated
- Non-Hodgkin's B-cell Lymphoma
- +5 more
- MT-3724 Phase 1
- MT-3724 Phase 2
-
Tucson, Arizona
- +40 more
Jul 18, 2022
Toxicity inHaematological Malignancy Treated With Immunotherapy.
Recruiting
- Blood Cancer
- Data collection
-
Paris, Ile De France, FranceAssistance Publique - Hôpitaux de Paris (AP-HP) - Cochin Hospita
Jul 5, 2022
Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH
Recruiting
- Chronic Graft-versus-Host-Disease
- +4 more
-
San Francisco, California
- +15 more
Jun 17, 2022
CNS Infections, CNS Complication, Infectious Disease of Nervous System Trial in Worldwide
Recruiting
- Central Nervous System Infections
- +5 more
-
Westmead, Australia
- +16 more
Jun 1, 2022
Blood Cancer Trial (KCAT19 T cells)
Not yet recruiting
- Blood Cancer
- KCAT19 T cells
- (no location specified)
May 20, 2022
The Leukemia and Lymphoma Society National Research Registry
Recruiting
- Blood Cancer
- any/all treatments for blood cancer
-
Rye Brook, New YorkLymphoma and Leukemia Society
Apr 5, 2022
Better Leukemia Diagnostics Through AI (BELUGA)
Recruiting
- Hematologic Malignancy
- +4 more
- Automated AI-Guided Diagnosis of Hematological Malignancies
-
Munich, Bavaria, GermanyMLL Munich Leukemia Laboratory
Apr 4, 2022
Leukemia, Lymphoma, Blood Cancer Trial in Baltimore (Bone Marrow Transplant (BMT))
Recruiting
- Leukemia
- +5 more
- Bone Marrow Transplant (BMT)
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Feb 14, 2022
Leukemia, Lymphoma, Multiple Myeloma Trial in Calgary (Early palliative and supportive care)
Not yet recruiting
- Leukemia
- +4 more
- Early palliative and supportive care
-
Calgary, Alberta, CanadaTom Baker Cancer Centre
Dec 29, 2021
Hematologic Malignancy, Hematopoietic/Lymphoid Cancer, Blood Cancer Trial in Boston (Positive Psychology Intervention)
Recruiting
- Hematologic Malignancy
- +2 more
- Positive Psychology Intervention
-
Boston, MassachusettsDana Farber Cancer Institute
Dec 20, 2021
IDH Mutation, IDH1 Mutation, IDH2 Gene Mutation Trial in Chicago (Ivosidenib, Enasidenib, Fedratinib)
Recruiting
- IDH Mutation
- +4 more
- Ivosidenib
- +2 more
-
Chicago, IllinoisUniversity of Chicago Medical Center
Nov 12, 2021
Blood Cancer Trial (Psychoeducation)
Withdrawn
- Blood Cancer
- Psychoeducation
- (no location specified)
Jul 14, 2021
Haematological Malignancy, Leukemia, Acute, Lymphoma Trial in Kuala Lumpur (WHODAS 2.0 Questionnaire)
Completed
- Haematological Malignancy
- +5 more
- WHODAS 2.0 Questionnaire
-
Kuala Lumpur, Wilayah Persekutuan, MalaysiaUniversity Malaya
Nov 2, 2020
Blood Cancer, Leukemia, GVHD Trial in Stanford (non-myeloablative hematopoietic cell transplantation, Anti-Thymocyte Globulin,
Completed
- Blood Cancer
- +7 more
- non-myeloablative hematopoietic cell transplantation
- +8 more
-
Stanford, CaliforniaStanford University School of Medicine
Nov 17, 2019
Blood Cancer, Advanced B Cell Malignancies Trial in Fukuoka-shi, Isehara-shi, Nagoya-shi (MEDI-551)
Completed
- Blood Cancer
- Advanced B Cell Malignancies
-
Fukuoka-shi, Japan
- +2 more
May 8, 2017
Myeloproliferative Disorders, Blood Cancer, MDS Trial in Stanford (Total Lymphoid Irradiation (TLI), Anti-Thymocyte Globulin as
Completed
- Myeloproliferative Disorders
- +2 more
- Total Lymphoid Irradiation (TLI)
- Anti-Thymocyte Globulin as Conditioning (ATG)
-
Stanford, CaliforniaStanford University School of Medicine
Mar 16, 2015
Blood Cancer, Breast Cancer, Prostatic Tumors Trial in Stanford, London (Cancer: Thriving and Surviving Online Workshop)
Completed
- Blood Cancer
- +4 more
- Cancer: Thriving and Surviving Online Workshop
-
Stanford, California
- +1 more
Feb 5, 2013